Similar articles for PMID: 37061693

Year	Number of Results
1996	1
1997	1
2002	1
2007	1
2008	2
2011	1
2012	1
2013	4
2014	3
2015	2
2016	6
2017	8
2018	7
2019	19
2020	23
2021	32
2022	22
2023	74
2024	64
2025	3

1

EXCHANGE-2: investigating the efficacy of add-on plasma exchange as an adjunctive strategy against septic shock-a study protocol for a randomized, prospective, multicenter, open-label, controlled, parallel-group trial.

David S, Bode C, Stahl K; EXCHANGE-2 Study group. David S, et al. Trials. 2023 Apr 15;24(1):277. doi: 10.1186/s13063-023-07300-5. Trials. 2023. PMID: 37061693 Free PMC article.

2

Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers.

Knaup H, Stahl K, Schmidt BMW, Idowu TO, Busch M, Wiesner O, Welte T, Haller H, Kielstein JT, Hoeper MM, David S. Knaup H, et al. Crit Care. 2018 Oct 30;22(1):285. doi: 10.1186/s13054-018-2220-9. Crit Care. 2018. PMID: 30373638 Free PMC article.

3

Clinical and biochemical endpoints and predictors of response to plasma exchange in septic shock: results from a randomized controlled trial.

Stahl K, Wand P, Seeliger B, Wendel-Garcia PD, Schmidt JJ, Schmidt BMW, Sauer A, Lehmann F, Budde U, Busch M, Wiesner O, Welte T, Haller H, Wedemeyer H, Putensen C, Hoeper MM, Bode C, David S. Stahl K, et al. Crit Care. 2022 May 12;26(1):134. doi: 10.1186/s13054-022-04003-2. Crit Care. 2022. PMID: 35551628 Free PMC article. Clinical Trial.

4

A pilot study of therapeutic plasma exchange for serious SARS CoV-2 disease (COVID-19): A structured summary of a randomized controlled trial study protocol.

Faqihi F, Alharthy A, Alodat M, Asad D, Aletreby W, Kutsogiannis DJ, Brindley PG, Karakitsos D. Faqihi F, et al. Trials. 2020 Jun 8;21(1):506. doi: 10.1186/s13063-020-04454-4. Trials. 2020. PMID: 32513290 Free PMC article.

5

The therapeutic efficacy of adjunct therapeutic plasma exchange for septic shock with multiple organ failure: a single-center experience.

Keith PD, Wells AH, Hodges J, Fast SH, Adams A, Scott LK. Keith PD, et al. Crit Care. 2020 Aug 24;24(1):518. doi: 10.1186/s13054-020-03241-6. Crit Care. 2020. PMID: 32831133 Free PMC article.

6

Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.

Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P. Crider K, et al. Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.

7

Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial.

Soto A, Krapp F, Vargas A, Cabrejos L, Argumanis E, García PL, Altamirano K, Montes M, Chacón-Uscamaita PR, García PJ. Soto A, et al. Trials. 2021 May 17;22(1):342. doi: 10.1186/s13063-021-05189-6. Trials. 2021. PMID: 34001174 Free PMC article.

8

The scientific rationale and study protocol for the DPP3, Angiotensin II, and Renin Kinetics in Sepsis (DARK-Sepsis) randomized controlled trial: serum biomarkers to predict response to angiotensin II versus standard-of-care vasopressor therapy in the treatment of septic shock.

Teixeira JP, Perez Ingles D, Barton JB, Dean JT, Garcia P, Kunkel SJ, Sarangarm P, Weiss NK, Schaich CL, Busse LW, Nielsen ND. Teixeira JP, et al. Trials. 2024 Mar 12;25(1):182. doi: 10.1186/s13063-024-07995-0. Trials. 2024. PMID: 38475822 Free PMC article.

9

Remote ischemic conditioning in septic shock (RECO-Sepsis): study protocol for a randomized controlled trial.

Cour M, Buisson M, Klouche K, Bouzgarrou R, Schwebel C, Quenot JP, Zeni F, Beuret P, Ovize M, Argaud L. Cour M, et al. Trials. 2019 May 22;20(1):281. doi: 10.1186/s13063-019-3406-4. Trials. 2019. PMID: 31118101 Free PMC article.

10

Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.

Emadi A, Chua JV, Talwani R, Bentzen SM, Baddley J. Emadi A, et al. Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9. Trials. 2020. PMID: 33115543 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

261 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 37061693

261 results

Results by year